Malaysia Announces Voluntary Pharmacovigilance Inspections From Jan 2023
Executive Summary
The Malaysian drug agency is inviting drug companies to voluntarily sign up to its new risk-based pharmacovigilance inspection program so that they can build and strengthen their internal systems before such inspections become mandatory.